Free Trial

Short Interest in Aspen Pharmacare Holdings Limited (OTCMKTS:APNHY) Expands By 566.7%

Aspen Pharmacare logo with Medical background

Aspen Pharmacare Holdings Limited (OTCMKTS:APNHY - Get Free Report) was the target of a significant increase in short interest during the month of April. As of April 15th, there was short interest totalling 2,000 shares, an increase of 566.7% from the March 31st total of 300 shares. Currently, 0.0% of the shares of the company are short sold. Based on an average daily trading volume, of 2,000 shares, the short-interest ratio is currently 1.0 days.

Aspen Pharmacare Trading Up 3.5 %

Shares of Aspen Pharmacare stock traded up $0.22 on Tuesday, hitting $6.59. 1,002 shares of the company's stock were exchanged, compared to its average volume of 1,384. The company has a current ratio of 1.81, a quick ratio of 1.07 and a debt-to-equity ratio of 0.30. Aspen Pharmacare has a 1 year low of $5.76 and a 1 year high of $13.69. The company has a 50-day simple moving average of $8.74 and a 200-day simple moving average of $9.21.

Aspen Pharmacare Company Profile

(Get Free Report)

Aspen Pharmacare Holdings Limited, together with its subsidiaries, manufactures and supplies specialty and branded pharmaceutical products worldwide. It operates in Commercial Pharmaceuticals and Manufacturing segments. The company provides general anesthetics, muscle relaxants, and topical agents under the Anaesthetics brand; and a range of injectable anticoagulants with a focus on low molecular weight heparins, Xa inhibitors, and heparin derivatives under the Thrombosis brand.

Further Reading

Should You Invest $1,000 in Aspen Pharmacare Right Now?

Before you consider Aspen Pharmacare, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aspen Pharmacare wasn't on the list.

While Aspen Pharmacare currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Stocks Offering Rare Generational Buying Opportunities
Make Your Money Work Harder: The Power of Dividend Investing
7 Cybersecurity Stocks Outperforming the Market Right Now

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines